CombinedX AB (FRA:K13) Research & Development: €0.00 Mil (TTM As of Mar. 2026)


FRA:K13 CombinedX AB FRA:K13
84 GF Score
Price €3.23
GF Value €3.46
! 8 Warning Signs
View Full Analysis

What is CombinedX AB Research & Development?

CombinedX AB FRA:K13 -0.92% 84 Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:K13 with a GF Score™ of 84/100 and a GF Value™ of €3.46. The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CombinedX AB's Research & Development for the three months ended in Mar. 2026 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil.

CombinedX AB  (FRA:K13) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CombinedX AB Research & Development Related Terms

CombinedX AB Research & Development Historical Data

* Premium members only.

The historical data trend for CombinedX AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CombinedX AB Research & Development Chart

CombinedX AB Annual Data
Trend Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

CombinedX AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:K13
84GF Score
CombinedX AB FRA:K13
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CombinedX AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
CombinedX AB (FRA:K13) has a Research & Development of €0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on CombinedX AB and its competitors.
Is CombinedX AB's Research & Development too high?
CombinedX AB's current Research & Development is €0.00 Mil. Overall, CombinedX AB has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does CombinedX AB's Research & Development compare to IBM and ACN?
CombinedX AB's Research & Development of €0.00 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CombinedX AB and its competitors. CombinedX AB's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CombinedX AB stock overvalued right now?
CombinedX AB (FRA:K13) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €3.46, compared to a current price of €3.23 — trading 6.6% below its estimated fair value. The current Research & Development is €0.00 Mil. CombinedX AB's overall GF Score™ is 84/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CombinedX AB (FRA:K13), the current Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CombinedX AB (FRA:K13) Overvalued in 2026?

Based on GuruFocus' analysis, CombinedX AB stock appears to be undervalued. The current stock price of €3.23 is trading 6.6% below its estimated GF Value™ of €3.46.

Key valuation signals for FRA:K13:

  • Research & Development: €0.00 Mil
  • GF Value™: €3.46 vs. price of €3.23 (6.6% below fair value)
  • GF Score™: 84/100 with 8 warning signs

No single metric tells the full story. See the FRA:K13 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CombinedX AB Business Description

Other Exchanges CX:Sweden
Address Tynasgatan 10, Karlstad, SWE, 652 16
CombinedX AB is a family of knowledge companies that help companies and organizations to take advantage of the opportunities of digitalisation. It delivers services through eight wholly-owned specialist companies, each with market-leading technology and business expertise in its niche.
84GF Score

Get the complete analysis for FRA:K13

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.23
Price
€3.46
GF Value